SCHEMBL10636413

SCHEMBL10636413

CC(=O)Nc1ccc(C2=NNC(=O)NC2C)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 7/20 0.64
▸ PDE3A Q14432 7/20 0.64
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ HTT P42858 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ PDE4A P27815 1/20 0.46
▸ PDE4B Q07343 1/20 0.46
▸ PDE4C Q08493 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ ERCC1 P07992 1/20 0.45
▸ ERCC4 Q92889 1/20 0.45
▸ NISCH Q9Y2I1 1/20 0.43
▸ MAPT P10636 4/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ RXFP1 Q9HBX9 2/20 0.43
▸ XDH P47989 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10887832 0.89 PDE3B (0.51) PDE3BPDE3ASMN1; SMN2HTTL3MBTL1
SCHEMBL10886795 0.87 PDE3B (0.49) PDE3BPDE3ASMN1; SMN2PDE4APDE4B
SCHEMBL10849412 0.86 PDE3B (0.57) PDE3BPDE3ASMN1; SMN2HTTL3MBTL1
SCHEMBL10633041 0.86 PDE3B (0.48) PDE3BPDE3ASMN1; SMN2PDE4APDE4B
SCHEMBL10888365 0.85 PDE3B (0.47) PDE3BPDE3ASMN1; SMN2PDE4APDE4B
SCHEMBL10852124 0.85 PDE3B (0.47) PDE3BPDE3ASMN1; SMN2HTTPDE4A
SCHEMBL10846981 0.85 GPR119 (0.47) PDE3BPDE3ASMN1; SMN2PDE4APDE4B
SCHEMBL10890398 0.84 PDE3B (0.46) PDE3BPDE3ASMN1; SMN2PDE4APDE4B
SCHEMBL10639087 0.84 TGM2 (0.47) PDE3BPDE3ASMN1; SMN2PDE4APDE4B
SCHEMBL10887732 0.84 ALDH1A1 (0.48) PDE3BPDE3ASMN1; SMN2HTTPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0123254-A1 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP claimed
EP-0123254-B1 TRIAZINE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-22 — — EP disclosed
US-4618610-A Triazine derivatives, and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-21 — — US disclosed
US-4616015-A HYPOTENSIVE AGENT, ANTULCER AGENT, ANTICOAGULANT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-07 — — US disclosed
US-4581356-A HYPOTENSIVE AND ANTIULCER AGENTS; ANTICOAGULANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-08 — — US disclosed
EP-0123254-A1 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
EP-0122494-A2 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-24 — — EP disclosed
EP-0122627-A2 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-24 — — EP disclosed
Send feedback